Photo: depositphotos.com
Feb 4, 2026, 16:55
Bhavesh Thakkar: The Most Dangerous Assumption About Aspirin Is That It’s “Simple”
Bhavesh Thakkar, Clinical Pharmacist Intern at Fortis Healthcare, shared a post on LinkedIn:
”The most dangerous assumption we make about Aspirin? That it’s ‘simple.’
During my rotations at Fortis, I’ve realized that Aspirin is perhaps the most misunderstood drug on the shelf.
We often treat it as a basic NSAID. But the data tells a much more complex story.
From ancient willow bark to the modern debates on primary prevention, the ‘Story of Aspirin’ is actually a lesson in how evidence-based medicine evolves.
I put together this timeline to track that journey.
Inside this breakdown:
- The ‘Willow Bark’ origins (long before Bayer).
- How it changed the way we treat inflammation.
- The shift in guidelines: Why ‘routine’ use is now being questioned.
- Slide 12 was the biggest realization for me regarding the risk/benefit ratio in modern practice.
Pharmacists and Medics:
When do you still recommend Aspirin for primary prevention? Or have you stopped completely?”
Stay informed with Hemostasis Today.
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease